Polymer Drugs in the Clinical Stage

Advantages and Prospects

  • Hiroshi Maeda
  • Alexander Kabanov
  • Kazunori Kataoka
  • Teruo Okano

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 519)

Table of contents

  1. Front Matter
    Pages i-viii
  2. Alexander V. Kabanov, Teruo Okano
    Pages 1-27
  3. Robert M. Hoffman
    Pages 69-79
  4. Jack W. Singer, Brian Baker, Peter de Vries, Anil Kumar, Scott Shaffer, Ed Vawter et al.
    Pages 81-99
  5. C. Matthew Peterson, Jane-Guo Shiah, Yongen Sun, Pavla KopeČKovÁ, Tamara Minko, Richard C. Straight et al.
    Pages 101-123
  6. Blanka ŘÍHovÁ, JiŘÍ Strohalm, KateŘIna KubÁČKovÁ, MarkÉTa JelÍNkovÁ, LaĎKa RozprimovÁ, Milada ŠÍRov Á et al.
    Pages 125-143
  7. Kazuhiro Inoue, Eiji Kumazawa, Hiroshi Kuga, Hiroshi Susaki, Noriko Masubuchi, Tetsuyo Kajimura
    Pages 145-153
  8. Alan C. Perkins
    Pages 195-205
  9. Kunihiko Nakai, Ichiro Sakuma, Hiroko Togashi, Mitsuhiro Yoshioka, Takeshi Sugawara, Hiroshi Satoh et al.
    Pages 207-216
  10. Back Matter
    Pages 217-224

About this book


Proceedings of the International Symposium on Polymer Therapeutics - Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan.

The technology of polymer science has developed considerably during the past half-century, and this volume describes some of the aspects of this technology that will have a great impact in the future. Among these advances, for example, are gene delivery to specific disease sites and carrier polymers that respond to a stimulus or particular environment. Cancer targeted drug delivery is another focused area of this volume because of the important nature of EPR-effect of polymer drugs in tumor. Included are discussions of as many examples as possible of polymer drugs that have achieved, or are close to clinical use. The concept of "Polymer drugs" here is limited to primarily injectable and water-soluble agents, although also covered are some drugs in micellar form or liposomes.

This book is intended for students and researchers in the field of pharmacology who have particular interests in drug delivery, targeting, and formulation, as well as for clinicians such as oncologists who are interested in the field. People who work at regulatory agencies should also be aware such that drugs with great potential are being developed and will be beneficial to many patients, as well as to health insurance agencies because of improved cost effectiveness.


Copolymer Epoxidharze Polyethylen imaging interferon polymer

Editors and affiliations

  • Hiroshi Maeda
    • 1
  • Alexander Kabanov
    • 2
  • Kazunori Kataoka
    • 3
  • Teruo Okano
    • 4
  1. 1.Kumamoto University School of MedicineKumamotoJapan
  2. 2.University of Nebraska Medical CenterOmaha
  3. 3.University of TokyoTokyoJapan
  4. 4.Tokyo Women’s Medical CollegeTokyoJapan

Bibliographic information

  • DOI
  • Copyright Information Kluwer Academic Publishers 2003
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-0-306-47471-2
  • Online ISBN 978-0-306-47932-8
  • Series Print ISSN 0065-2598
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Pharmacology & Toxicology
Consumer Packaged Goods